First Time Loading...
C

Changzhou Qianhong Biopharma Co Ltd
SZSE:002550

Watchlist Manager
Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
Watchlist
Price: 5.87 CNY 0.69% Market Closed
Updated: May 21, 2024

Changzhou Qianhong Biopharma Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Changzhou Qianhong Biopharma Co Ltd
Net Income (Common) Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
C
Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
Net Income (Common)
¥200m
CAGR 3-Years
N/A
CAGR 5-Years
-2%
CAGR 10-Years
0%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Net Income (Common)
¥3.3B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Net Income (Common)
¥3B
CAGR 3-Years
19%
CAGR 5-Years
20%
CAGR 10-Years
21%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Net Income (Common)
¥4.4B
CAGR 3-Years
-12%
CAGR 5-Years
1%
CAGR 10-Years
13%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Net Income (Common)
¥4.3B
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
6%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Net Income (Common)
-¥780.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Changzhou Qianhong Biopharma Co Ltd's Net Income (Common)?
Net Income (Common)
200m CNY

Based on the financial report for Mar 31, 2024, Changzhou Qianhong Biopharma Co Ltd's Net Income (Common) amounts to 200m CNY.

What is Changzhou Qianhong Biopharma Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
0%

Over the last year, the Net Income (Common) growth was -29%.